Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies

Apple Watch Series 11 offers new sleep features

On Sept. 9, Apple introduced the Apple Watch Series 11, which includes new tools to help users track and improve sleep quality. Sleep score tracks quality and patterns The Apple Watch Series 11 collects sleep data such as heart rate, wrist [...]

2025-09-25T14:14:04-05:00September 19th, 2025|Industry|

Compumedics receives FDA clearance for Somfit-D

On Sept. 4, 2025, Compumedics announced that it received FDA 510(k) clearance for Somfit-D, a single-use, home-based sleep monitoring device that records signals from a patient’s forehead. About Somfit-D Somfit-D is a noninvasive, single-use prescription device designed for home use in [...]

2025-09-25T15:47:54-05:00September 18th, 2025|Industry|

Nox launches self-applied PSG solution in U.S.

On August 14, 2025, Nox Medical announced the U.S. launch of the Nox SAS solution, an advanced EEG technology that enables polysomnography (PSG) testing in any setting. About Nox SAS Nox SAS, short for self-applied somnography, is a simplified EEG montage developed for [...]

2025-08-22T14:56:15-05:00August 22nd, 2025|Industry|

Nyxoah receives FDA approval for Genio system

On Aug. 8, 2025, Nyxoah announced that the FDA approved the Genio system for a subset of patients with moderate to severe obstructive sleep apnea (OSA) who have an apnea-hypopnea index (AHI) between 15 and 65. About Genio Genio is a hypoglossal nerve [...]

2025-08-27T14:00:07-05:00August 15th, 2025|Industry|

FDA clears DeltaWave nasal pillow CPAP mask

In July 2024, REMSleep Holdings received FDA 510(k) clearance for its DeltaWave Nasal Pillow System, a CPAP interface mask designed to improve comfort and airflow for patients undergoing positive airway pressure therapy. About REMSleep’s DeltaWave mask The DeltaWave Nasal Pillow System is a [...]

2025-07-16T17:49:29-05:00July 3rd, 2025|Industry|

Centessa receives FDA clearance to begin clinical trial of ORX142

Centessa Pharmaceuticals announced that the U.S. FDA has cleared its investigational new drug (IND) application for ORX142, a novel orexin receptor 2 agonist in development for sleep-wake disorders and select neurological and neurodegenerative conditions. About ORX142 ORX142 is an investigational, novel, highly potent [...]

2025-06-26T15:23:47-05:00June 24th, 2025|Industry|

ProSomnus adds new oral appliance to FDA-cleared EVO line

ProSomnus has expanded its EVO line with a new oral appliance designed for obstructive sleep apnea. Called EVO Guided, the company says it is the first bioengineered oral device intentionally designed to dilate both the velopharynx and the oropharynx. About EVO Guided ProSomnus EVO [...]

2025-06-18T13:53:36-05:00June 16th, 2025|Industry|
Go to Top